Prescription drugs : companies typically charge more in the United States than in the United Kingdom : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

Medicaid : changes in best price for outpatient drugs purchased by HMOs and hospitals : fact sheet for the Chairman, Subcommittee on Regulation, Business Opportunities, and Technology, Committee on Small Business, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology.

"B-252845"--P. 1."GAO/HEHS-94-194FS.""August 1994."Cover title.Includes bibliographical references.M...

The high cost of prescription drugs : hearing before the Select Committee on Aging, House of Representatives, One Hundred First Congress, second session, May 18, 1990, Baltimore, MD.

United States. Congress. House. Select Committee on Aging.

January 1990

Item 1009-B-2, 1009-C-2 (MF)."Comm. pub. no. 101-769."Shipping list no.: 90-598-P.Distributed to som...

Prescription drug prices : outpricing older Americans : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Bangor, Maine, April 14, 1993.

United States. Congress. Senate. Special Committee on Aging.

January 1993

"Serial no. 103-2."Shipping list no.: 93-0529-P.Distributed to some depository libraries in microfic...

Prescription drugs : companies typically charge more in the United States than in Canada : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"B-249553"--P. 1."GAO/HRD-92-110.""September 1992."Cover title.Includes bibliographical references (...

Prescription drugs : companies typically charge more in the United States than in Canada : statement of Janet L. Shikles, Director, Health Financing and Policy Issues, Human Resources Division, before the Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

Shikles, Janet.
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
United States. General Accounting Office.

"February 22, 1993."Cover title.Includes bibliographical references.Mode of access: Internet

Prescription drugs : spending controls in four European countries : report to the Chairman, Special Committee on Aging, U.S. Senate /

United States. General Accounting Office.
United States. Congress. Senate. Special Committee on Aging.

"B-251111"--P. [1]."GAO/HEHS-94-30.""May 1994."Cover title.Includes bibliographical references.Mode ...

Prescription drug prices : official index overstates producer price inflation : report to the Chairman, Special Committee on Aging, U.S. Senate /

United States. General Accounting Office.
United States. Congress. Senate. Special Committee on Aging.

"B-260293"--P. 1."GAO/HEHS-95-90.""April 1995."Cover title.Includes bibliographical references (p. 2...

Prescription drugs : changes in prices for selected drugs : report to Congressional requesters /

United States. General Accounting Office.

"B-249510"--P. 1."GAO/HRD-92-128."Cover title."August 1992."Includes bibliographical references.Mode...

Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

Jaggar, Sarah F.
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
United States. General Accounting Office.

"September 19, 1996."Cover title.Includes bibliographical references (p. 8).Mode of access: Internet

Prescription drug prices : analysis of Canada's Patented Medicine Prices Review Board : report to the Chairman, Special Committee on Aging, U.S. Senate /

United States. General Accounting Office.
United States. Congress. Senate. Special Committee on Aging.

"GAO/HRD-93-51.""B-247942"--P. 1."February 1993."Cover title.Includes bibliographical references.Mod...

User fees for prescription drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, August 10, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"Serial no. 102-161."Shipping list no.: 93-0122-P.Distributed to some depository libraries in microf...

International prescription drug prices : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, first session, February 22, 1993.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"Serial no. 103-18."Shipping list no.: 93-0504-P.Distributed to some depository libraries in microfi...

Prescription drug costs : what drives increases? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, 106th Congress, 2nd session ... July 18, 2000.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2001-0024-P.Distributed to some depository libraries in microfiche."Printed for t...

Prescription drug monitoring : states can readily identify illegal sales and use of controlled substances : report to the Chairman, Subcommittee on Health, Committee on Ways and Means, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.

"GAO/HRD-92-115.""B-248618"--P. 1.Cover title."July 1992."Includes bibliographical references.Mode o...

Prescribed medicines in ambulatory care settings : a comparison of use, expenditures, and sources of payment, 1977 and 1987 /

Moeller, John F.
Levy, Helen.
Center for General Health Services Intramural Research (U.S.)

"August 1995"--P. [4] of cover.At head of title: National Medical Expenditure Survey.Cover title.Inc...

Medicaid : changes in best price for outpatient drugs purchased by HMOs and hospitals : fact sheet for the Chairman, Subcommittee on Regulation, Business Opportunities, and Technology, Committee on Small Business, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology.

"B-252845"--P. 1."GAO/HEHS-94-194FS.""August 1994."Cover title.Includes bibliographical references.M...

The high cost of prescription drugs : hearing before the Select Committee on Aging, House of Representatives, One Hundred First Congress, second session, May 18, 1990, Baltimore, MD.

United States. Congress. House. Select Committee on Aging.

January 1990

Item 1009-B-2, 1009-C-2 (MF)."Comm. pub. no. 101-769."Shipping list no.: 90-598-P.Distributed to som...

Prescription drug prices : outpricing older Americans : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Bangor, Maine, April 14, 1993.

United States. Congress. Senate. Special Committee on Aging.

January 1993

"Serial no. 103-2."Shipping list no.: 93-0529-P.Distributed to some depository libraries in microfic...

Prescription drugs : companies typically charge more in the United States than in Canada : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"B-249553"--P. 1."GAO/HRD-92-110.""September 1992."Cover title.Includes bibliographical references (...

Prescription drugs : companies typically charge more in the United States than in Canada : statement of Janet L. Shikles, Director, Health Financing and Policy Issues, Human Resources Division, before the Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

Shikles, Janet.
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
United States. General Accounting Office.

"February 22, 1993."Cover title.Includes bibliographical references.Mode of access: Internet

Prescription drugs : spending controls in four European countries : report to the Chairman, Special Committee on Aging, U.S. Senate /

United States. General Accounting Office.
United States. Congress. Senate. Special Committee on Aging.

"B-251111"--P. [1]."GAO/HEHS-94-30.""May 1994."Cover title.Includes bibliographical references.Mode ...

Prescription drug prices : official index overstates producer price inflation : report to the Chairman, Special Committee on Aging, U.S. Senate /

United States. General Accounting Office.
United States. Congress. Senate. Special Committee on Aging.

"B-260293"--P. 1."GAO/HEHS-95-90.""April 1995."Cover title.Includes bibliographical references (p. 2...

Prescription drugs : changes in prices for selected drugs : report to Congressional requesters /

United States. General Accounting Office.

"B-249510"--P. 1."GAO/HRD-92-128."Cover title."August 1992."Includes bibliographical references.Mode...

Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

Jaggar, Sarah F.
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
United States. General Accounting Office.

"September 19, 1996."Cover title.Includes bibliographical references (p. 8).Mode of access: Internet

Prescription drug prices : analysis of Canada's Patented Medicine Prices Review Board : report to the Chairman, Special Committee on Aging, U.S. Senate /

United States. General Accounting Office.
United States. Congress. Senate. Special Committee on Aging.

"GAO/HRD-93-51.""B-247942"--P. 1."February 1993."Cover title.Includes bibliographical references.Mod...

User fees for prescription drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, August 10, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"Serial no. 102-161."Shipping list no.: 93-0122-P.Distributed to some depository libraries in microf...

International prescription drug prices : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, first session, February 22, 1993.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"Serial no. 103-18."Shipping list no.: 93-0504-P.Distributed to some depository libraries in microfi...

Prescription drug costs : what drives increases? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, 106th Congress, 2nd session ... July 18, 2000.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2001-0024-P.Distributed to some depository libraries in microfiche."Printed for t...

Prescription drug monitoring : states can readily identify illegal sales and use of controlled substances : report to the Chairman, Subcommittee on Health, Committee on Ways and Means, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.

"GAO/HRD-92-115.""B-248618"--P. 1.Cover title."July 1992."Includes bibliographical references.Mode o...

Prescribed medicines in ambulatory care settings : a comparison of use, expenditures, and sources of payment, 1977 and 1987 /

Moeller, John F.
Levy, Helen.
Center for General Health Services Intramural Research (U.S.)

"August 1995"--P. [4] of cover.At head of title: National Medical Expenditure Survey.Cover title.Inc...

Medicaid : changes in best price for outpatient drugs purchased by HMOs and hospitals : fact sheet for the Chairman, Subcommittee on Regulation, Business Opportunities, and Technology, Committee on Small Business, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology.

"B-252845"--P. 1."GAO/HEHS-94-194FS.""August 1994."Cover title.Includes bibliographical references.M...

The high cost of prescription drugs : hearing before the Select Committee on Aging, House of Representatives, One Hundred First Congress, second session, May 18, 1990, Baltimore, MD.

United States. Congress. House. Select Committee on Aging.

January 1990

Item 1009-B-2, 1009-C-2 (MF)."Comm. pub. no. 101-769."Shipping list no.: 90-598-P.Distributed to som...

Prescription drug prices : outpricing older Americans : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Bangor, Maine, April 14, 1993.

United States. Congress. Senate. Special Committee on Aging.

January 1993

"Serial no. 103-2."Shipping list no.: 93-0529-P.Distributed to some depository libraries in microfic...

Prescription drugs : companies typically charge more in the United States than in the United Kingdom : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

Abstract

Extracted data

Prescription drugs : companies typically charge more in the United States than in the United Kingdom : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

Abstract

Extracted data

Related items

Related items